A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence
Condition: Opioid Dependence Interventions: Drug: 0.2mg group; Drug: 0.5mg group; Drug: placebo control group Sponsors: Wei Hao; Beijing ziduhongye technology development co. LTD; Institute of Pharmacology and Toxicology, Academy of Military Medical Science; Shanghai Mental Health Center; West China Hospital; Wuhan Mental Health Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Biomedical Science | Drugs & Pharmacology | Hospitals | Men | Research | Science | Study | Toxicology